Mezyl

Mezyl
MezylMezylMezylMezyl
Antiinfectives For Systemic Use
Albania & Kosovo
No
Yes
No
SA00260
Mezyl
125 mg/5 ml - 120 ml
Oral suspension
Metronidazole benzoate
Box x bottle x 120 ml
Oral suspension - 125 mg/5 ml - 120 ml Mezyl contains the active ingredient metronidazole. Metronidazole, a synthetic derivative of nitroimidazole, i … Read more

Oral suspension - 125 mg/5 ml - 120 ml

Mezyl contains the active ingredient metronidazole. Metronidazole, a synthetic derivative of nitroimidazole, is active against several anaerobic gram-positive and gram-negative microorganisms (Bacteroides fragilis and other Bacteroides spp., Clostridium spp., Eubacterium spp., Peptococcus spp., and Peptostreptococcus spp.) and several protozoa (Trichomonas vaginalis, Entamoeba histolytica and Giardia lamblia). The mechanism of action of metronidazole is not entirely clear, but it is thought to inhibit DNA synthesis. Metronidazole has a bactericidal action.

It is indicated in:

  • treatment of infections caused by anaerobic microorganisms, and protozoan infections;
  • the prevention of post-operative infections due to anaerobic bacteria, particularly species of Bacteroides and anaerobic Streptococci;
  • treatment of septicaemia, bacteraemia, peritonitis, brain abscesses, necrotizing pneumonia, osteomyelitis, puerperal sepsis, pelvic abscesses, pelvic cellulitis and post-operative wound infections from which pathogenic anaerobes have been isolated, urogenital trichomoniasis in females (trichomonal vaginitis) and in males; bacterial vaginosis (known as nonspecific vaginitis), anaerobic vaginosis or Gardnerella vaginitis;
  • acute ulcerative gingivitis; anaerobically-infected leg ulcers or pressure sores;
  • acute dental infections (e.g. acute pericoronitis and acute apical infections);
  • all forms of amoebiasis (intestinal and extra-intestinal disease) and symptomless cyst passers;
  • giardiasis;
  • eradication of Helicobacter pylori, in combination with other drugs.

 

Recently viewed

Film coated tablets - 400mg 

Avacyn contains the active substance moxifloxacin hyrochloride, which belongs to a group of antibiotics called fluoroquinolones. Avacyn works by killing bacteria that cause infections. It is used in patients aged 18 years and above for treating the following bacterial infections when caused by bacteria against which moxifloxacin is active.

Avacyn is used for treating the following bacterial infections, when usual antibiotics cannot be used or have not worked:

  • infection of the sinuses (acute bacterial sinusitis);
  • acute exacerbations of chronic bronchitis;
  • community acquired penumonia outside the hospital (except severe cases);
  • mild to moderate infections of the female upper genital tract (pelvic inflammatory disease), including infections of the fallopian tubes and infections of the uterus mucous membrane        

Avacyn film-coated tablets are not sufficient on their own for treating this kind of infection, therefore, another antibiotic in addition to Avacyn film-coated tablets should be prescribed by your doctor for the treatment of infections of the female upper genital tract.

Avacyn film-coated tablets may also be used to complete a course of therapy in patients who have shown improvement during initial treatment with intravenous moxifloxacin for the following indications:

  • complicated skin and skin structure infections;
  • community acquired pneumonia.

Avacyn tablets should not be used to initiate therapy for any type of infections of the skin and soft tissue or in severe infections of the lungs.

Tablets - 25 mg

Film coated tablets - 180 mg

 

Solution for infusion - 400 mg/250 ml

Solution for injection - (0.1%) 1 mg/1 ml